Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: impact on pathological complete response and safety

BACKGROUND: Gastric cancer is the fifth cause of cancer incidence worldwide. Multidisciplinary approaches that improve the survival are needed. Perioperative chemotherapies show improvement in pathological complete remission (pCR) and overall survival (OS), but less than 50% of the patients complete...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ecancermedicalscience
Auteurs principaux: Villanueva, Luis, Anabalon, Jaime, Butte, Jean M, Salman, Pamela, Panay, Sergio, Milla, Elizabeth, Gallardo, Carlos, Hoefler, Sebastian, Charles, Roberto, Reyes, Felipe, Barajas, Olga, Matamala, Luis, Molina, Angelica, Portiño, Sergio, Berrios, Marcela, Caglevic, Christian, Mahave, Mauricio
Format: Artigo
Langue:Inglês
Publié: Cancer Intelligence 2021
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7929772/
https://ncbi.nlm.nih.gov/pubmed/33680082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2021.1168
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires